Market Research Logo

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development


Attention: There is an updated edition available for this report.

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:

  • Stem Cell Therapeutics (Transplantation)
  • Cord Blood Banking and
  • Drug development
This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:
  • Cardiovascular disease
  • Lung disease
  • Arthritis
  • Incontinence
  • Osteoporosis
  • Diabetes
  • Cancer
  • Orthopedics
  • Infertility
  • Alzheimer’s disease
  • Burns (severe)
  • Lupus
  • Parkinson’s disease
  • Liver failure
  • Multiple sclerosis
  • Critical limb ischemia
  • Crohn's disease
  • Sickle cell disease
  • Multiple myeloma
  • NH lymphoma
  • Leukemia
Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:
  • Aastrom Biosciences
  • Advanced Cell Technologies
  • Brainstorm Cell Therapeutics
  • Celegene
  • Cord Blood America
  • Cord Blood Registry
  • Cryo-Cell International
  • ES Cell International
  • Geron
  • Harvest Technologies
  • Invitrogen
  • Medistem
  • Neostem
  • Opexa Therapeutics
  • Osiris Therapeutics
  • Plureon
  • Regenetech
  • Revivicor
  • Stem Cell Sciences
  • StemLifeLine
  • ThermoGenesis
  • VetCell Bioscience
  • ViaCell
License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.


  • Executive Summary
    • SCOPE AND METHODOLOGY
    • INTRODUCTION
    • CURRENT STEM CELL THERAPIES
    • DEVELOPMENTAL STEM CELL THERAPIES
    • ISSUES IN STEM CELL RESEARCH
      • Embryonic Stem Cells
      • Non-Embryonic Stem Cells
    • STEM CELL FORECASTS
      • Table Total Market for Stem Cell Technologies in $ Millions, 2007-2020
      • Table Stem Cell Therapeutics Market in $ Millions, 2007-2020
      • Table Total Market for Cord Blood Banking Fees in $ Millions, 2007-2020
      • Table Total Market for Stem Cell Drug Development Technologies in $ Millions, 2007-2020
  • Introduction
    • THE PROMISE OF STEM CELLS IN MEDICAL TREATMENT
    • TYPES OF STEM CELLS
      • Embryonic Stem Cells
      • Adult Stem Cells
      • Cord Blood Stem Cells
    • STEM CELL HARVESTING
      • Embryonic Stem Cells
      • Adult Stem Cells
      • Cord Blood Stem Cells
    • TRANSPLANTATION APPROACHES
      • Autologous Transplantation
      • Allogenic Transplantation
    • TRANSPLANTATION PROCEDURES
    • CANCEROUS STEM CELLS
      • Other Harmful Stem Cells
    • STEM CELLS IN DRUG DEVELOPMENT
    • STEM CELL THERAPEUTICS
      • Stem Cell Targeting Drugs
      • Stem Cell Generated Organs
  • Current Stem Cell Therapies
    • CANCER
      • Leukemia
        • Table Types of Leukemia, 2007
      • Multiple Myeloma
      • Non-Hodgkin's Lymphoma
    • NONCANCEROUS DISEASES
      • Aplastic Anemia
      • Immunodeficiency
      • Lupus
      • Sickle Cell Disease
      • Other Conditions
  • Developmental Stem Cell Therapies
    • Table Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007
    • ALZHEIMER'S DISEASE
    • ARTHRITIS
    • BURNS
    • CANCER
      • Table Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020
      • Table Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020
    • CARDIOVASCULAR CONDITIONS
    • CRITICAL LIMB ISCHEMIA
    • CROHN'S DISEASE
    • DIABETES
    • INCONTINENCE
      • Table Types and Features of Urinary Incontinence, 2007
    • INFERTILITY
      • Table Types and Causes of Male Infertility, 2007
    • LIVER FAILURE
    • LUNG DISEASE
      • Table Common Diseases of the Lungs, 2007
    • MULTIPLE SCLEROSIS
    • ORTHOPEDICS
    • OSTEOPOROSIS
    • PARKINSON'S DISEASE
    • SICKLE CELL DISEASE
  • Stem Cell Forecasts
    • Table Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007
    • BEST CASE
      • Stem Cell Therapeutics
        • Table Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020
        • Table Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020
      • Umbilical Cord Blood Banking
        • Table Best Case: Cord Blood Banking Revenues in $ Millions, 2007-2020
      • Fees Related to Drug Development
        • Table Best Case: Stem Cell-Based Drug Development Technology Fees, 2007-2020 (Preclinical Drug Candidates, Cost of Testing, Utilization of New Technology, Cost of New Technolgy per Drug)
        • Table Best Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2007-2020
    • MOST LIKELY CASE
      • Stem Cell Therapeutics
        • Table Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020
        • Table Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020
      • Umbilical Cord Blood Banking
        • Table Most Likely Case: Cord Blood Banking Revenues in $ Millions, 2007- 2020
      • Fees Related to Drug Development
        • Table Most Likely Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2007-2020
        • Table Most Likely Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2007-2020
    • WORST CASE
      • Stem Cell Therapeutics
        • Table Worst Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020
        • Table Stem Cell Applications by Therapeutic Area, 2020
        • Table Worst Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020
      • Umbilical Cord Blood Banking
        • Table Worst Case: Cord Blood Banking Revenues in $ Millions, 2007 - 2020
      • Fees Related to Drug Development
        • Table Worst Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2007-2020
        • Table Worst Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2007-2020
  • Issues in Stem Cell Research
    • ETHICAL QUESTIONS
    • U.S. STATE AND FEDERAL INITIATIVES
      • Cord Blood Initiatives
      • Policy Initiatives
      • Research Funding
        • Table NIH Funding for Stem Cell Research in $ Million, 2003-2008 (est.)
    • INTERNATIONAL INITIATIVES
      • Table Positions on Human ES Cell Research by Country, 2007
    • STEM CELL PATENTS
  • Company Profiles
    • Table Main Activities of Selected Stem Cell Companies, 2007
    • Table Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007
    • AASTROM BIOSCIENCES
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • ADVANCED CELL TECHNOLOGIES
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • BRAINSTORM CELL THERAPEUTICS
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • CELEGENE
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • CORD BLOOD AMERICA
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • CORD BLOOD REGISTRY
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • CRYO-CELL INTERNATIONAL
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • ES CELL INTERNATIONAL
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • GERON
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • HARVEST TECHNOLOGIES
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • INVITROGEN
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • MEDISTEM
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • NEOSTEM
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • OPEXA THERAPEUTICS
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • OSIRIS THERAPEUTICS
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • PLUREON
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • REGENETECH
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • REVIVICOR
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • STEM CELL SCIENCES
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • STEMLIFELINE
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • THERMOGENESIS
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • VETCELL BIOSCIENCE
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology
    • ViaCell
      • History and Lines of Business
      • Financial Information
      • Stem Cell Technology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report